2023 American College of Rheumatology (ACR) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Disease      AB9490E2CBB5C4579E5F0776547A04FE ACR Board of Directors on 12 August 2023. These recommendations are included in a full manuscript, pending peer review, which was submitted for publication in Arthritis & Rheumatology and Arthritis Care and Research.  Table 1. Summary of recommendations for screening of SARD-ILD Summary of recommendations For people with SARDs at increased risk of developing ILD, we conditionally recommend screening with PFTs. For people with SARDs at increased risk of developing ILD, we conditionally recommend screening with HRCT of the chest. For people with SARDs at increased risk of developing ILD, we conditionally recommend screening with HRCT chest and PFTs over PFTs alone. For people with SARDs at increased risk of developing ILD, we conditionally recommend against screening with 6MWD.